Literature DB >> 16168222

Derivation of a human blastocyst after heterologous nuclear transfer to donated oocytes.

Miodrag Stojkovic1, Petra Stojkovic, Christine Leary, Vanessa Jane Hall, Lyle Armstrong, Mary Herbert, Maria Nesbitt, Majlinda Lako, Alison Murdoch.   

Abstract

This paper describes the derivation of a blastocyst following heterologous nuclear transfer (NT) into a human oocyte. It also demonstrates that a major obstacle to continuing research in human NT is the availability of suitable human oocytes. In this study, 36 oocytes were donated by 11 women undergoing four different treatments and their developmental potential was evaluated after NT. The time from oocyte collection to NT seems to be crucial, and only oocytes that were enucleated within 1 h proved successful. After enucleation of oocytes, fusion with undifferentiated human embryonic stem cells and in-vitro culture, early cleavage and blastocyst development of fused complexes was observed. The DNA fingerprinting comparison of the donor cells and derived blastocyst revealed successful heterologous NT, since both oocytes and donor cells were recovered from different patients. It has therefore been demonstrated that NT can be achieved in humans, using heterologous donor nuclei and surplus and donated oocytes. However, if the promise of this new science is to achieve its potential in the foreseeable future, it will be necessary to identify new sources of oocytes that can be used immediately after retrieval.

Entities:  

Mesh:

Year:  2005        PMID: 16168222     DOI: 10.1016/s1472-6483(10)60962-5

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  29 in total

Review 1.  Delineating nuclear reprogramming.

Authors:  Jolene Ooi; Pentao Liu
Journal:  Protein Cell       Date:  2012-03-31       Impact factor: 14.870

2.  [Embryonic stem cells. Future perspectives].

Authors:  M Groebner; R David; W M Franz
Journal:  Internist (Berl)       Date:  2006-05       Impact factor: 0.743

3.  A caffeine fix for human nuclear transfer?

Authors:  Anthony C F Perry
Journal:  Nat Biotechnol       Date:  2013-08       Impact factor: 54.908

Review 4.  Reprogrammed pluripotent stem cells from somatic cells.

Authors:  Jong Soo Kim; Hyun Woo Choi; Sol Choi; Jeong Tae Do
Journal:  Int J Stem Cells       Date:  2011-06       Impact factor: 2.500

5.  Developments and challenges in human embryonic stem cell research in Spain.

Authors:  R P Cervera; M Stojkovic
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

Review 6.  The future of human nuclear transfer?

Authors:  Lyle Armstrong; Majlinda Lako
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

7.  From embryonic stem cells to iPS - an ethical perspective.

Authors:  J Suaudeau
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

8.  Derivation of a new human embryonic stem cell line, Endeavour-2, and its characterization.

Authors:  Kuldip S Sidhu; John P Ryan; Justin G Lees; Bernard E Tuch
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-23       Impact factor: 2.416

9.  Derivation of induced pluripotent stem cells by lentiviral transduction.

Authors:  Hubert E Nethercott; David J Brick; Philip H Schwartz
Journal:  Methods Mol Biol       Date:  2011

Review 10.  Patient-specific pluripotent stem cells: promises and challenges.

Authors:  Rouven Müller; Claudia Lengerke
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.